These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29615501)

  • 41. Optical Control of Genome Editing by Photoactivatable Cas9.
    Otabe T; Nihongaki Y; Sato M
    Methods Mol Biol; 2021; 2312():225-233. PubMed ID: 34228293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Highly efficient genome editing by homology-directed repair using Cas9 protein in Ceratitis capitata.
    Aumann RA; Schetelig MF; Häcker I
    Insect Biochem Mol Biol; 2018 Oct; 101():85-93. PubMed ID: 30157456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An Agrobacterium-delivered CRISPR/Cas9 system for high-frequency targeted mutagenesis in maize.
    Char SN; Neelakandan AK; Nahampun H; Frame B; Main M; Spalding MH; Becraft PW; Meyers BC; Walbot V; Wang K; Yang B
    Plant Biotechnol J; 2017 Feb; 15(2):257-268. PubMed ID: 27510362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CRISPR/Cas9 in Genome Editing and Beyond.
    Wang H; La Russa M; Qi LS
    Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CRISPR-Cas9 Genome Editing in Human Cell Lines with Donor Vector Made by Gibson Assembly.
    Sahoo N; Cuello V; Udawant S; Litif C; Mustard JA; Keniry M
    Methods Mol Biol; 2020; 2115():365-383. PubMed ID: 32006411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Harnessing CRISPR/Cas9 technology in cardiovascular disease.
    Rezaei H; Khadempar S; Farahani N; Hosseingholi EZ; Hayat SMG; Sathyapalan T; Sahebkar AH
    Trends Cardiovasc Med; 2020 Feb; 30(2):93-101. PubMed ID: 30935726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances in Industrial Biotechnology Using CRISPR-Cas Systems.
    Donohoue PD; Barrangou R; May AP
    Trends Biotechnol; 2018 Feb; 36(2):134-146. PubMed ID: 28778606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. gRNA-transient expression system for simplified gRNA delivery in CRISPR/Cas9 genome editing.
    Easmin F; Hassan N; Sasano Y; Ekino K; Taguchi H; Harashima S
    J Biosci Bioeng; 2019 Sep; 128(3):373-378. PubMed ID: 31010727
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CRISPR-Cas systems: ushering in the new genome editing era.
    Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
    Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.
    Wang Z; Wang W; Cui YC; Pan Q; Zhu W; Gendron P; Guo F; Cen S; Witcher M; Liang C
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Highly Efficient Targeted Gene Editing in Upland Cotton Using the CRISPR/Cas9 System.
    Zhu S; Yu X; Li Y; Sun Y; Zhu Q; Sun J
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CRISPR/Cas9-Based Multiplex Genome Editing in Monocot and Dicot Plants.
    Ma X; Liu YG
    Curr Protoc Mol Biol; 2016 Jul; 115():31.6.1-31.6.21. PubMed ID: 27366892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CRISPR: development of a technology and its applications.
    Derry WB
    FEBS J; 2021 Jan; 288(2):358-359. PubMed ID: 33300275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CRISPR/Cas9-mediated gene replacement in the basidiomycetous yeast Pseudozyma antarctica.
    Kunitake E; Tanaka T; Ueda H; Endo A; Yarimizu T; Katoh E; Kitamoto H
    Fungal Genet Biol; 2019 Sep; 130():82-90. PubMed ID: 31026589
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design and Assembly of CRISPR/Cas9 Lentiviral and rAAV Vectors for Targeted Genome Editing.
    Sandoval IM; Collier TJ; Manfredsson FP
    Methods Mol Biol; 2019; 1937():29-45. PubMed ID: 30706388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing.
    Naeem M; Majeed S; Hoque MZ; Ahmad I
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pea early-browning virus-mediated genome editing via the CRISPR/Cas9 system in Nicotiana benthamiana and Arabidopsis.
    Ali Z; Eid A; Ali S; Mahfouz MM
    Virus Res; 2018 Jan; 244():333-337. PubMed ID: 29051052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CRISPR-Mediated Base Editing Enables Efficient Disruption of Eukaryotic Genes through Induction of STOP Codons.
    Billon P; Bryant EE; Joseph SA; Nambiar TS; Hayward SB; Rothstein R; Ciccia A
    Mol Cell; 2017 Sep; 67(6):1068-1079.e4. PubMed ID: 28890334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conditional Control of CRISPR/Cas9 Function.
    Zhou W; Deiters A
    Angew Chem Int Ed Engl; 2016 Apr; 55(18):5394-9. PubMed ID: 26996256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.